These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 3336577)

  • 1. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
    Boner AL; Sette L; Vallone G; Plebani M; Messori A
    Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic equivalence of a generic slow-release theophylline tablet.
    Hendeles L; Breton AL; Beaty R; Harman E
    Pharmacotherapy; 1995; 15(1):26-35. PubMed ID: 7739942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E; Baba M
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
    Steinijans VW; Sauter R; Böhm A; Staudinger H
    Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets.
    Kelly HW; Murphy S
    Am J Hosp Pharm; 1979 Dec; 36(12):1698-701. PubMed ID: 525646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-a-day dosing with theophylline: a comparison of four sustained-release products.
    Minotti DA; Altman LC; Ayars GH; Popick FR; Benn VJ
    Ann Allergy; 1992 Jun; 68(6):500-6. PubMed ID: 1610026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of theophylline. Repeated single evening administration of Pulmo-Timelets slow-release capsules in comparison with theophylline slow-release tablets].
    Heusinger JH; Breuel HP; Behrendt WA; Wolfstädter HD
    Fortschr Med; 1989 Nov; 107(32):692-6. PubMed ID: 2689314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
    Tal A; Aviram M; Gorodischer R
    J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release theophylline therapy for chronic childhood asthma.
    Bell T; Bigley J
    Pediatrics; 1978 Sep; 62(3):352-8. PubMed ID: 704210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and chronotherapy of delayed action theophylline (Euphyllin CR)].
    Vondra V; Spicák V; Trnavská Z; Reisová M; Pohunek P; Tomíska F
    Cas Lek Cesk; 1989 May; 128(19):595-8. PubMed ID: 2743384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
    Hendeles L; Iafrate RP; Weinberger M
    Clin Pharmacokinet; 1984; 9(2):95-135. PubMed ID: 6370542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
    Liebke C; Niggemann B; Wahn U
    Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children.
    Kelly HW; Murphy S
    Pediatrics; 1980 Jul; 66(1):97-102. PubMed ID: 7402798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
    Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.